TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novartis Sverige AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,001,849
|
1,649,366
|
1,606,038 |
Financial expenses |
12,268
|
8,644
|
6,187 |
Earnings before taxes |
57,521
|
58,433
|
64,004 |
EBITDA |
71,534
|
69,607
|
72,810 |
Total assets |
752,118
|
661,352
|
585,933 |
Current assets |
738,074
|
647,215
|
569,337 |
Current liabilities |
345,598
|
306,606
|
283,570 |
Equity capital |
133,596
|
94,687
|
111,514 |
- share capital |
5,065
|
4,730
|
4,876 |
Employees (average) |
189
|
206
|
216 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.8%
|
14.3%
|
19.0% |
Turnover per employee |
10,592
|
8,007
|
7,435 |
Profit as a percentage of turnover |
2.9%
|
3.5%
|
4.0% |
Return on assets (ROA) |
9.3%
|
10.1%
|
12.0% |
Current ratio |
213.6%
|
211.1%
|
200.8% |
Return on equity (ROE) |
43.1%
|
61.7%
|
57.4% |
Change turnover |
235,449
|
91,597
|
-5,809 |
Change turnover % |
13%
|
6%
|
0% |
Chg. No. of employees |
-17
|
-10
|
-12 |
Chg. No. of employees % |
-8%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.